NEFL and multiple sclerosis: In this regard, NfL is already recognized as a sensitive diagnostic, monitoring, prognostic, and predictive biomarker of neuroaxonal damage in many other neurological conditions (i.e., multiple sclerosis), a circumstance that should ensure to shortly fill the gap regarding the need for standardization of blood sample collection and NfL measurement to be applied in different laboratories.